Reinbold, Emily D <br/><br/>
Central CRF2 receptor antagonism reduces anxiety states during amphetamine withdrawal.  [electronic resource] 

 -  Neuroscience research  Dec 2014 
 - 37-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8111 
<br/><br/><label>Standard No.: </label>10.1016/j.neures.2014.08.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amphetamine--pharmacology<br/>Animals<br/>Anxiety--chemically induced<br/>Infusions, Intraventricular<br/>Male<br/>Motor Activity--drug effects<br/>Peptide Fragments--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Corticotropin-Releasing Hormone--antagonists & inhibitors<br/>Substance Withdrawal Syndrome--psychology<br/>CRF Receptor, Type 1